Volume 64, Issue 3 (1 2006)                   Tehran Univ Med J 2006, 64(3): 69-77 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

M. Adel Ghahraman, F. Hajiabolhassan, M. Naraghi, M. Sedaei, E. Entezari, M. Haddadi Avval et al . Variables affecting canalith repositioning maneuver (CRM) trend for treating patients with benign paroxysmal positional vertigo (BPPV). Tehran Univ Med J. 2006; 64 (3) :69-77
URL: http://tumj.tums.ac.ir/article-1-976-en.html
Abstract:   (5191 Views)

Background: The purpose of this study was to identify variables affecting outcome in patients with benign paroxysmal positional vertigo (BPPV) treated with canalith repositioning maneuver (CRM).

Methods: This interventional study was conducted on 58 patients (14 males, 44 females, mean age 48.12+13.22) referred to the Vertigo Rehabilitation Clinic of the Rehabilitation School of Tehran University of Medical Sciences from 2002 to 2004. All patients were treated with CRM. According to the treatment efficacy the patients were allocated in three groups: completely treated, partially treated, and not treated. The effect of factors including age, sex, etiology, duration of BPPV, unilateral or bilateral disease, number of maneuvers, and number of sessions on outcome in patients was evaluated.

Results: Forty-nine patients (84.5%) were completely cured. Age, sex, etiology, and duration did not significantly affect the treatment outcome. Unilateral BPPV can be treated significantly better than bilateral BPPV. Forty-seven patients who were completely treated needed 1 session and thirty-seven of them required 2 maneuvers.

Conclusion: CRM is significantly effective for BPPV treatment. Treating unilateral BPPV is expected to be easier. As most of the patients will be cured by 1 or 2 maneuvers or in 1 session, patients who required more sessions or more maneuvers may not be completely treated.

Full-Text [PDF 163 kb]   (1220 Downloads)    

Add your comments about this article : Your username or Email:
CAPTCHA code